ARCHIVES

NIH Extramural Office Lists Initiatives For Reinvention

This article is from The Cancer Letter archive.

Vol. 21 No. 02 | January 13, 1995

Download PDF Visit The Full Archive

Related Articles

NCI apologize For Mismanagement Of NSABP, Says Fisher Resisted Criticism

April 22, 1994

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990

NIH Advisors Urge Overhaul Of Peer Review System.

March 7, 2008

In Brief: Pittsburgh Joins List Of Comprehensive Center Prospect; FDA Schedules Meeting On Cancer Drugs

July 11, 1975

FIT More Effective Than gFOBT In All Colonoscopy Capacities

November 25, 2011

Retraction Based On Data Given To Duke Last November, But Apparently Disregarded

October 29, 2010